{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-22-001328","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2022-06-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.335274+00:00","generated_at":"2026-06-24T23:55:10.499273+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Lexaria enters manufacturing and license agreements with BevNology for DehydraTECH CBD tech","bullets":["Manufacturing operating agreement for fee-based production of DehydraTECH-enabled APIs for corporate clients.","Five-year global non-exclusive license for hemp CBD (<0.3% THC) in bulk powders, liquids, and finished consumer products.","Exclusions: Japan, South Korea, China; limited exclusive US rights for bulk liquids subject to minimum fee.","No financial terms disclosed; agreements described as non-material."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-22-001328","json":"https://secwatch.observer/filing/0001640334-22-001328.json","markdown":"https://secwatch.observer/filing/0001640334-22-001328.md","text":"https://secwatch.observer/filing/0001640334-22-001328.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033422001328/0001640334-22-001328-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033422001328/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T23:55:10.499273+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}